Latin Metals Inc. ('Latin Metals' or the 'Company') (TSXV: LMS)(OTCQB: LMSQF) is pleased to provide shareholders with an overview of project advancement achieved during 2025 and the exploration and ...
Bristol Myers Squibb today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos (mavacamten) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback